Resmed Inc
Resmed Inc (RMD) Covered Calls
As of September 25, 2026, RMD has 31 covered call opportunities in the coming three months. Return ranges from 4.8 to 44.3% until expiration. Annualized return ranges from 21.1 to 220.8%. The nearest expiration is October 16, 2026. Maximum potential profit is $9,835.
Read more
Running RMD covered calls helps you generate consistent income from Resmed Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Resmed Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best RMD covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if RMD stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling RMD covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Resmed Inc covered call is worth writing.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.
The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Income-focused investors, long-term RMD holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling RMD covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Resmed Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Instruments & Supplies
- SectorHealthcare
- IV percentile50.00% Neutral
- Market cap (M$)32,038
- 52 weeks high-22.03%
- 52 weeks low23.21%
- Analyst recommendationBuy
2.07 - Target price$262.31
18.10% above the current stock price - Dividend—
- Payout ratio23.01%
- Earnings date2026-10-29
- P/E21.28
- Future P/E16.69
- EPS (ttm)10.44
- EPS growth next 5 years9.27%
As of September 25, 2026
| 2026-10-16 | 21 | 250.00 | 12.61 | 0.20 | 1.30 | 2820.00 | 12.70 | 220.79 | -0.09 | +0.09 | 705 | 1.10 |
| 2026-10-16 | 21 | 240.00 | 8.11 | 0.85 | 2.80 | 1885.00 | 8.49 | 147.58 | -0.38 | +0.19 | 398 | 1.95 |
| 2026-11-20 | 56 | 270.00 | 21.62 | 0.70 | 1.55 | 4870.00 | 21.94 | 142.98 | -0.32 | +0.09 | 7 | 0.85 |
| 2026-11-20 | 56 | 260.00 | 17.12 | 1.40 | 2.80 | 3940.00 | 17.75 | 115.68 | -0.63 | +0.14 | 3 | 1.40 |
| 2026-12-18 | 84 | 280.00 | 26.13 | 0.75 | 3.10 | 5875.00 | 26.46 | 114.99 | -0.34 | +0.11 | 2 | 2.35 |
| 2027-01-15 | 112 | 290.00 | 30.63 | 0.80 | 3.20 | 6880.00 | 30.99 | 101.00 | -0.36 | +0.11 | 60 | 2.40 |
| 2026-12-18 | 84 | 270.00 | 21.62 | 1.20 | 3.90 | 4920.00 | 22.16 | 96.30 | -0.54 | +0.15 | 0 | 2.70 |
| 2026-11-20 | 56 | 250.00 | 12.61 | 3.00 | 3.90 | 3100.00 | 13.96 | 91.02 | -1.35 | +0.22 | 55 | 0.90 |
| 2027-01-15 | 112 | 280.00 | 26.13 | 1.30 | 3.80 | 5930.00 | 26.71 | 87.05 | -0.59 | +0.13 | 176 | 2.50 |
| 2026-10-16 | 21 | 230.00 | 3.60 | 2.55 | 3.40 | 1055.00 | 4.75 | 82.60 | -1.15 | +0.32 | 185 | 0.85 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best RMD covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→